Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 104, Issue , 2016, Pages 171-179

  McConville, Christopher ^a   Major, Ian ^b   Devlin, Brid ^c   Brimer, Andrew ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Athletic Rehabilitation Therapy Ireland   (Ireland)

^c INTERNATIONAL PARTNERSHIP FOR MICROBICIDES   (United States)

Author keywords

Acyclovir; Contraception; Dapivirine; HIV microbicides; Levonorgestrel; Multipurpose prevention technology; Sexually transmitted infections

Indexed keywords

ACICLOVIR; DAPIVIRINE; LEVONORGESTREL; PYRIMIDINE DERIVATIVE; TABLET; TMC120-R147681;

ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; IN VITRO STUDY; MEDICAL TECHNOLOGY; MULTIPURPOSE PREVENTION TECHNOLOGY; PREVENTION; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE PREPARATION; TABLET; TABLET FRIABILITY; TABLET HARDNESS; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HIV INFECTIONS; HUMAN; VAGINA;

ACYCLOVIR; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; LEVONORGESTREL; PYRIMIDINES; TABLETS; VAGINA;

EID: 84966372859     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.05.003     Document Type: Article

References (46)

1. D.R. Friend, J.T. Clark, P.F. Kiser, and M.R. Clark Multipurpose prevention technologies: products in development Antiviral Res. 100 2013 S39 S47
2. www.cami-health.org/mpts (last accessed 18 January 2016).
3. A.R. Thurman, M.R. Clark, and G.F. Doncel Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies Infect. Dis. Obstet. Gynecol. 2011 2011 1 10
4. M.F. Gallo, D.A. Grimes, L.M. Lopez, and K.F. Schulz Non-latex versus latex male condoms for contraception Cochrane Database Syst. Rev. 2006 CD003550
5. K.R. Davis, and S.C. Weller The effectiveness of condoms in reducing heterosexual transmission of HIV Fam. Plann. Perspect. 31 1999 272 279
6. D. Mansour, P. Inki, and K. Gemzell-Danielsson Efficacy of contraceptive methods: a review of the literature Eur. J. Contracept. Reprod. Health Care 15 2010 4 16
7. E.L. Gollub Choice is empowering: getting strategic about preventing HIV infection in women Int. Fam. Plann. Perspect. 32 2006 209 212
8. J. Trussell, K. Sturgen, J. Strickler, and R. Dominik Comparative contraceptive efficacy of the female condom and other barrier methods Fam. Plann. Perspect. 26 1994 66 72
9. G. Farr, H. Gabelnick, K. Sturgen, and L. Dorflinger Contraceptive efficacy and acceptability of the female condom Am. J. Public Health 84 1994 1960 1964
10. P.P. French, M. Latka, E.L. Gollub, C. Rogers, D.R. Hoover, and Z.A. Stein Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women Sex. Transm. Dis. 30 2003 433 439
11. M. Warren, and A. Philpott Expanding safer sex options: introducing the female condom into national programmes Reprod. Health Matters 11 2003 130 139
12. R.A. Hatcher, J. Trussell, A.L. Nelson, W. Cates, F.H. Stewart, and D. Kowal Contraceptive Technology 2007 Ardent Media New York
13. World Health Organization The Safety and Feasibility of Female Condom Reuse: Report of a WHO Consultation 2002 World Health Organization Geneva, Switzerland
14. L. Cook, K. Nanda, and D. Grimes Diaphragm versus diaphragm with spermicides for contraception Cochrane Database Syst. Rev. 2001 CD002031
15. B.K. Patterson, A. Landay, J. Andersson, C. Brown, H. Behbahani, D. Jiyamapa, Z. Burki, D. Stanislawski, M.A. Czerniewski, and P. Garcia Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission Am. J. Pathol. 153 1998 481 490
16. Q. Li, J.D. Estes, P.M. Schlievert, L. Duan, A.J. Brosnahan, P.J. Southern, C.S. Reilly, M.L. Peterson, N. Schultz-Darken, K.G. Brunner, K.R. Nephew, S. Pambuccian, J.D. Lifson, J.V. Carlis, and A.T. Haase Glycerolmonolaurate prevents mucosal SIV transmission Nature 458 2009 1034 1038
17. T.R. Moench, T. Chipato, and N.S. Padian Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices AIDS 15 2001 1595 1602
18. A.M. Minnis, and N.S. Padian Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions Sex. Transm. Infect. 8 2005 193 200
19. N.S. Padian, A. van der Straten, G. Ramjee, T. Chipato, G. de Bruyn, K. Blanchard, S. Shiboski, E.T. Montgomery, H. Fancher, H. Cheng, M. Rosenblum, M. van der Laan, N. Jewell, J. McIntyre MIRA Team Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial The Lancet 370 2007 251 261
20. G. Ramjee, A. van der Straten, T. Chipato, G. de Bruyn, K. Blanchard, S. Shiboski, H. Cheng, E. Montgomery, N. Padian The MIRA Team The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial PLoS One 3 2008 e3488
21. J.L. Schwartz, S.A. Ballagh, M.D. Creinin, R.W. Rountree, M. Kilbourne-Brook, C.K. Mauck, and M.M. Callahan SILCS diaphragm: postcoital testing of a new single-size contraceptive device Contraception 78 2008 237 244
22. I. Major, P. Boyd, M. Kilbourne-Brook, G. Saxon, J. Cohen, and R.K. Malcolm A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine Contraception 88 2013 58 66
23. Q.A. Karim, S.S.A. Karim, J.A. Frohlich, A.C. Grobler, C. Baxter, L.E. Mansoor, A.B. Kharsany, S. Sibeko, K.P. Mlisana, Z. Omar, T.N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, D. Taylor CAPRISA 004 Trial Group Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
24. A.M. Nel, L.B. Mitchnick, P. Risha, L.T. Muungo, and P.M. Norick Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women J. Womens Health 20 2011 1207 1214
25. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin. Ther. 23 2001 1296 1310
26. S. Abdul, and S.S. Poddar A flexible technology for modified release of drugs: multi layered tablets J. Control. Release 97 2004 393 405
27. E. Baloǧlu, and T. Senyiǧit A design and evaluation of layered matrix tablet formulations of metoprolol tartrate AAPS PharmSciTech 11 2010 563 573
28. M. Efentakis, and C. Peponaki Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on carbopols with isosorbite mononitrate AAPS PharmSciTech 9 2008 917 923
29. Z. Khan, Y.E. Choonara, P. Kumar, L.C. du Toit, V.M. Ndesendo, and V. Pillay A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery Biomed. Res. Int. 2013 569470
30. N. Chidambaram, W. Porter, K. Flood, and Y. Qiu Formulation and characterization of new layered diffusional matrices for zero-order sustained release J. Control. Release 52 1998 149 158
31. Y. Qiu, N. Chidambaram, and K. Flood Design and evaluation of layered diffusional matrices for zero-order sustained-release J. Control. Release 51 1998 123 130
32. U. Conte, and L. Maggi A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets J. Control. Release 64 2000 263 268
33. A. Streubel, J. Siepmann, N.A. Peppas, and R. Bodmeier Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design J. Control. Release 69 2000 455 468
34. P.D. Chaudhari Current trends in solid dispersions techniques Pharm. Rev. 4 2006 2 12
35. S. Janssens, and G. Van den Mooter Review: physical chemistry of solid dispersions J. Pharm. Pharmacol. 61 2009 1571 1586
36. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
37. J.P. Moschwitzer Drug nanocrystals in the commercial pharmaceutical development process Int. J. Pharm. 453 2012 142 156
38. M. Maniruzzaman, J.S. Boateng, M. Bonnefille, A. Aranyos, J.C. Mitchell, and D. Douroumis Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 80 2012 433 442
39. D. Douroumis Practical approaches of taste masking technologies in oral solid forms Expert Opin. Drug Deliv. 4 2007 417 426
40. D. Douroumis Orally disintegrating dosage forms and taste-masking technologies Expert Opin. Drug Deliv. 8 2008 665 675
41. A. Gryczke, S. Schminke, M. Maniruzzaman, J. Beck, and D. Douroumis Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion Colloids Surf. B: Biointerfaces 86 2011 275 284
42. J.M. Dealy, and K.F. Wissburn Melt Rheology and its Role in Plastics Processing fourth ed. 1999 Kluwer Academic Publishers Netherlands
43. C.A. Hiebar Melt viscosity characterisation and its application to injection molding A.I. Isayev, Injection and Compression Molding Fundamentals 1989 Marcel Dekker New York 1 136
44. K.B. Liew, Y.T. Tan, and K.K. Peh Effect of polymer, plasticizer and filler on orally disintegrating film Drug Dev. Ind. Pharm. 40 2014 110 119
45. H. Choi du, D.G. Lim, H.M. Son, and S.H. Jeong Comprehensive evaluation of layer separation tendency of novel three-layered tablets with geometric and mechanical properties Int. J. Pharm. 465 2014 347 359
46. S. Yoshioka, and V.J. Stella Stability of Drugs and Dosage Forms 2002 Kluwer Academic Publishers New York